246 related articles for article (PubMed ID: 28156161)
21. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
Pandey SK; Patel DK; Maurya AK; Thakur R; Mishra DP; Vinayak M; Haldar C; Maiti P
Int J Biol Macromol; 2016 Aug; 89():99-110. PubMed ID: 27112980
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of cyclosporine A/HPβCD-incorporated PLGA nanoparticles for development of effective ocular preparations.
Aksungur P; Demirbilek M; Denkbaş EB; Unlü N
J Microencapsul; 2012; 29(6):605-13. PubMed ID: 22432850
[TBL] [Abstract][Full Text] [Related]
23. Bioflavonoid Fisetin Loaded α-Tocopherol-Poly(lactic acid)-Based Polymeric Micelles for Enhanced Anticancer Efficacy in Breast Cancers.
Wang L; Zhang DZ; Wang YX
Pharm Res; 2017 Feb; 34(2):453-461. PubMed ID: 28004315
[TBL] [Abstract][Full Text] [Related]
24. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
[TBL] [Abstract][Full Text] [Related]
25. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
26. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
Baek JS; Kim JH; Park JS; Cho CW
Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
[TBL] [Abstract][Full Text] [Related]
27. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs.
Banerjee AA; Shen H; Hautman M; Anwer J; Hong S; Kapetanovic IM; Liu Y; Lyubimov AV
Curr Pharm Biotechnol; 2013; 14(4):464-9. PubMed ID: 23590143
[TBL] [Abstract][Full Text] [Related]
29. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.
De Rosa G; Larobina D; Immacolata La Rotonda M; Musto P; Quaglia F; Ungaro F
J Control Release; 2005 Jan; 102(1):71-83. PubMed ID: 15653135
[TBL] [Abstract][Full Text] [Related]
30. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
[TBL] [Abstract][Full Text] [Related]
31. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
32. Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation.
Wang F; Blanco E; Ai H; Boothman DA; Gao J
J Pharm Sci; 2006 Oct; 95(10):2309-19. PubMed ID: 16883563
[TBL] [Abstract][Full Text] [Related]
33. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
[TBL] [Abstract][Full Text] [Related]
34. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
35. Folic acid functionalized nanoparticles for enhanced oral drug delivery.
Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J
Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575
[TBL] [Abstract][Full Text] [Related]
36. Inducing G2/M Cell Cycle Arrest and Apoptosis through Generation Reactive Oxygen Species (ROS)-Mediated Mitochondria Pathway in HT-29 Cells by Dentatin (DEN) and Dentatin Incorporated in Hydroxypropyl-β-Cyclodextrin (DEN-HPβCD).
Ashwaq AS; Al-Qubaisi MS; Rasedee A; Abdul AB; Taufiq-Yap YH; Yeap SK
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763535
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes.
Fasehee H; Zarrinrad G; Tavangar SM; Ghaffari SH; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():587-95. PubMed ID: 27040254
[TBL] [Abstract][Full Text] [Related]
38. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
[TBL] [Abstract][Full Text] [Related]
39. Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy.
Feng C; Yuan X; Chu K; Zhang H; Ji W; Rui M
Int J Biol Macromol; 2019 Mar; 125():700-710. PubMed ID: 30521927
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
